Literature DB >> 16051428

Inhibition of breast cancer cell growth and induction of cell death by 1,1-bis(3'-indolyl)methane (DIM) and 5,5'-dibromoDIM.

Kathy Vanderlaag1, Ismael Samudio, Robert Burghardt, Rola Barhoumi, Stephen Safe.   

Abstract

1,1-Bis(3'-indolyl)methane (DIM) and the 5,5'-dibromo ring substituted DIM (5,5'-diBrDIM) inhibited growth of MCF-7 and MDA-MB-231 breast cancer cells, and IC50 values were 10-20 and 1-5 microM, respectively, in both cell lines. DIM and 5,5'-diBrDIM did not induce p21 or p27 protein levels or alter expression of Sp1 or Sp3 proteins in either cell line. In contrast, 10 microM 5,5'-diBrDIM downregulated cyclin D1 protein in MCF-7 and MDA-MB-231 cells 12 and 24 h after treatment. DIM (20 microM) also decreased cyclin D1 in MCF-7 (24 h) and MDA-MB-231 (12 h), and the DIM/5,5'-diBrDIM-induced degradation of cyclin D1 was blocked by the proteasome inhibitor MG132. Both DIM and 5,5'-diBrDIM induced apoptosis in MCF-7 cells and this was accompanied by decreased Bcl-2, release of mitochondrial cytochrome c, and decreased mitochondrial membrane potential as determined by the red/green fluorescence of JC-1. DIM and 5,5'-diBrDIM induced extensive necrosis in MDA-MB-231 cells; however, this was accompanied by decreased mitochondrial membrane potential primarily in cells treated with 5,5'-diBrDIM but not DIM. Thus, DIM and 5,5'-diBrDIM induce cell death in MCF-7 and MDA-MB-231 cells by overlapping and different pathways, and the ring-substituted DIM represents a novel class of uncharged mitochondrial poisons that inhibit breast cancer cell and tumor growth.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16051428     DOI: 10.1016/j.canlet.2005.05.036

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  3,3'-Diindolylmethane (DIM) inhibits the growth and invasion of drug-resistant human cancer cells expressing EGFR mutants.

Authors:  Massod Rahimi; Kai-Ling Huang; Careen K Tang
Journal:  Cancer Lett       Date:  2010-03-17       Impact factor: 8.679

2.  Lipid-based oral delivery systems for skin deposition of a potential chemopreventive DIM derivative: characterization and evaluation.

Authors:  Cedar H A Boakye; Ketan Patel; Apurva R Patel; Henrique A M Faria; Valtencir Zucolotto; Stephen Safe; Mandip Singh
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

Review 3.  Redox-directed cancer therapeutics: molecular mechanisms and opportunities.

Authors:  Georg T Wondrak
Journal:  Antioxid Redox Signal       Date:  2009-12       Impact factor: 8.401

4.  Peroxisome proliferator-activated receptor gamma-dependent activity of indole ring-substituted 1,1-bis(3'-indolyl)-1-(p-biphenyl)methanes in cancer cells.

Authors:  Jingjing Guo; Sudhakar Chintharlapalli; Syng-ook Lee; Sung Dae Cho; Ping Lei; Sabitha Papineni; Stephen Safe
Journal:  Cancer Chemother Pharmacol       Date:  2009-10-13       Impact factor: 3.333

Review 5.  Cancer chemotherapy with indole-3-carbinol, bis(3'-indolyl)methane and synthetic analogs.

Authors:  Stephen Safe; Sabitha Papineni; Sudhakar Chintharlapalli
Journal:  Cancer Lett       Date:  2008-05-22       Impact factor: 8.679

Review 6.  Indole-3-carbinol as a chemopreventive and anti-cancer agent.

Authors:  Jing-Ru Weng; Chen-Hsun Tsai; Samuel K Kulp; Ching-Shih Chen
Journal:  Cancer Lett       Date:  2008-03-07       Impact factor: 8.679

7.  5,5'-Dibromo-bis(3'-indolyl)methane induces Kruppel-like factor 4 and p21 in colon cancer cells.

Authors:  Sung Dae Cho; Sudhakar Chintharlapalli; Maen Abdelrahim; Sabitha Papineni; Shengxi Liu; Jingjing Guo; Ping Lei; Ala Abudayyeh; Stephen Safe
Journal:  Mol Cancer Ther       Date:  2008-07       Impact factor: 6.261

8.  1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes induce autophagic cell death in estrogen receptor negative breast cancer.

Authors:  Kathy Vanderlaag; Yunpeng Su; Arthur E Frankel; Robert C Burghardt; Rola Barhoumi; Gayathri Chadalapaka; Indira Jutooru; Stephen Safe
Journal:  BMC Cancer       Date:  2010-12-03       Impact factor: 4.430

9.  Chemoprevention of skin cancer with 1,1-Bis (3'-indolyl)-1-(aromatic) methane analog through induction of the orphan nuclear receptor, NR4A2 (Nurr1).

Authors:  Cedar H A Boakye; Ravi Doddapaneni; Punit P Shah; Apurva R Patel; Chandraiah Godugu; Stephen Safe; Santosh K Katiyar; Mandip Singh
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.